These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 27799831)

  • 1. Skin models for the testing of transdermal drugs.
    Abd E; Yousef SA; Pastore MN; Telaprolu K; Mohammed YH; Namjoshi S; Grice JE; Roberts MS
    Clin Pharmacol; 2016; 8():163-176. PubMed ID: 27799831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models.
    Godin B; Touitou E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1152-61. PubMed ID: 17889400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternatives to Biological Skin in Permeation Studies: Current Trends and Possibilities.
    Neupane R; Boddu SHS; Renukuntla J; Babu RJ; Tiwari AK
    Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32070011
    [No Abstract]   [Full Text] [Related]  

  • 4. Alternative Methods to Animal Studies for the Evaluation of Topical/ Transdermal Drug Delivery Systems.
    Garcia MTJ; de Vasconcellos FLL; Raffier CP; Roberts MS; Grice JE; Benson HAE; Leite-Silva VR
    Curr Top Med Chem; 2018; 18(4):287-299. PubMed ID: 29651933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Permeation kinetics of active drugs through lanolin-based artificial membranes.
    Alonso C; Collini I; Carrer V; Barba C; Martí M; Coderch L
    Colloids Surf B Biointerfaces; 2020 Apr; 192():111024. PubMed ID: 32388029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstructed Human Epidermis: An Alternative Approach for In Vitro Bioequivalence Testing of Topical Products.
    Agonia AS; Palmeira-de-Oliveira A; Cardoso C; Augusto C; Pellevoisin C; Videau C; Dinis-Oliveira RJ; Palmeira-de-Oliveira R
    Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 35893811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug.
    Leal LB; Cordery SF; Delgado-Charro MB; Bunge AL; Guy RH
    Pharm Res; 2017 Apr; 34(4):730-737. PubMed ID: 28097506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permeability test for transdermal and local therapeutic patches using Skin PAMPA method.
    Vizserálek G; Berkó S; Tóth G; Balogh R; Budai-Szűcs M; Csányi E; Sinkó B; Takács-Novák K
    Eur J Pharm Sci; 2015 Aug; 76():165-72. PubMed ID: 25957747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional skin models as tools for transdermal drug delivery: challenges and limitations.
    Van Gele M; Geusens B; Brochez L; Speeckaert R; Lambert J
    Expert Opin Drug Deliv; 2011 Jun; 8(6):705-20. PubMed ID: 21446890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confocal Raman Spectroscopy for Assessing Bioequivalence of Topical Formulations.
    Iliopoulos F; Tang CF; Li Z; Rahma A; Lane ME
    Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal drug delivery in vitro using diffusion cells.
    Bartosova L; Bajgar J
    Curr Med Chem; 2012; 19(27):4671-7. PubMed ID: 22934776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal Permeation of Drugs in Various Animal Species.
    Todo H
    Pharmaceutics; 2017 Sep; 9(3):. PubMed ID: 28878145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the in vitro permeation of ibuprofen in mammalian skin, the PAMPA model and silicone membrane.
    Luo L; Patel A; Sinko B; Bell M; Wibawa J; Hadgraft J; Lane ME
    Int J Pharm; 2016 May; 505(1-2):14-9. PubMed ID: 27025294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo Skin Permeation Evaluation of An Innovative Transdermal Vehicle Using Nimesulide and Piroxicam as Model Drugs.
    Pereira RO; Pelisson E Silva TCC; de Oliveira Ferreira A; Brandao MAF; Raposo NRB; Polonini HC
    Curr Drug Deliv; 2017; 14(4):516-520. PubMed ID: 27557671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in skin mimic systems to predict transdermal permeation.
    Waters LJ
    Curr Pharm Des; 2015; 21(20):2725-32. PubMed ID: 25925123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal iontophoretic delivery of tacrine hydrochloride: Correlation between in vitro permeation and in vivo performance in rats.
    Patel N; Jain S; Lin S
    Int J Pharm; 2016 Nov; 513(1-2):393-403. PubMed ID: 27633278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal delivery systems.
    Merkle HP
    Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):135-53. PubMed ID: 2657273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation.
    Ahmed TA; El-Say KM; Aljaeid BM; Fahmy UA; Abd-Allah FI
    Int J Pharm; 2016 Mar; 500(1-2):245-54. PubMed ID: 26775063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro/in vivo correlations in transdermal product development.
    Ghosh P; Milewski M; Paudel K
    Ther Deliv; 2015; 6(9):1117-24. PubMed ID: 26419538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R; Zia H; Needham TE
    Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.